Victrex (LON:VCT) Stock Price Crosses Above 200 Day Moving Average - What's Next?

Victrex plc (LON:VCT - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,025.54 ($12.94) and traded as high as GBX 1,148 ($14.49). Victrex shares last traded at GBX 1,148 ($14.49), with a volume of 321,457 shares traded.

Analyst Ratings Changes

Separately, Berenberg Bank cut their price target on Victrex from GBX 1,290 ($16.28) to GBX 1,170 ($14.77) and set a "hold" rating for the company in a research note on Wednesday, December 4th.

Victrex Stock Performance

The company has a market cap of £993.88 million, a PE ratio of 3,260.29, a P/E/G ratio of 1.92 and a beta of 0.69. The company's fifty day moving average price is GBX 911.20 and its 200 day moving average price is GBX 1,025.54. The company has a debt-to-equity ratio of 16.99, a current ratio of 5.30 and a quick ratio of 1.99.

Victrex Increases Dividend

The firm also recently announced a dividend, which will be paid on Friday, February 21st. Stockholders of record on Thursday, January 23rd will be paid a GBX 46.14 ($0.58) dividend. This represents a dividend yield of 5.26%. The ex-dividend date is Thursday, January 23rd. This is an increase from Victrex's previous dividend of $13.42. Victrex's payout ratio is presently 17,142.86%.

Insider Activity at Victrex

In other Victrex news, insider Jane Toogood purchased 508 shares of the stock in a transaction dated Tuesday, September 24th. The shares were bought at an average price of GBX 937 ($11.83) per share, with a total value of £4,759.96 ($6,007.77). Also, insider Brendan Connolly purchased 980 shares of the business's stock in a transaction dated Tuesday, December 3rd. The stock was bought at an average cost of GBX 1,019 ($12.86) per share, with a total value of £9,986.20 ($12,604.06). 1.64% of the stock is currently owned by company insiders.

About Victrex

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.